Cargando…
Restoration of HBV-specific CD8(+) T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy
Patients with chronic hepatitis B (CHB) undergoing interferon (IFN)-α-based therapies often exhibit a poor HBeAg serological response. Thus, there is an unmet need for new therapies aimed at CHB. This study comprised two clinical trials, including 130 CHB patients, who were treatment-naïve; in the f...
Autores principales: | Wang, Dongyao, Fu, Binqing, Shen, Xiaokun, Guo, Chuang, Liu, Yanyan, Zhang, Junfei, Sun, Rui, Ye, Ying, Li, Jiabin, Tian, Zhigang, Wei, Haiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569154/ https://www.ncbi.nlm.nih.gov/pubmed/34737296 http://dx.doi.org/10.1038/s41392-021-00776-0 |
Ejemplares similares
-
Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24(+)CD38(hi) B Cells
por: Fu, Binqing, et al.
Publicado: (2020) -
NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016) -
KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B
por: Li, Wenting, et al.
Publicado: (2017) -
CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients
por: Guo, Chuang, et al.
Publicado: (2016) -
Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
por: Wang, Dongyao, et al.
Publicado: (2019)